43 results
20-F/A
2021 FY
REPCF
Replicel Life Sciences Inc.
12 Sep 22
Annual report (foreign) (amended)
6:17pm
private practice, as a teaching professor in the Department of Dermatology for Marburg University, Germany, as well as a researcher on histopathogically … - Chief Scientific Officer
Dr. McElwee is an Associate Professor in the Department of Dermatology and Skin Health at the University of British
6-K
EX-99.3
REPCF
Replicel Life Sciences Inc.
21 Dec 21
51-102F3 Material Change Report
5:28pm
the DermaPrecise development, testing, and manufacturing (A.M.I.), and MainPointe’s regulatory department committed to handling all aspects of the regulatory
6-K
EX-99.1
REPCF
Replicel Life Sciences Inc.
18 Aug 21
RepliCel Applies for Manufacturing Approval for its Collagen and Tissue Regeneration Cell Therapies
12:38pm
to try and treat it,” stated Dr. Ross Davidson, an orthopedic surgeon, former clinical professor at the Department of Orthopaedics at the University
6-K
EX-99.1
0hn3j00y
18 Aug 21
Current report (foreign)
12:20pm
6-K
EX-99.3
h2nq5xmf e7g1ohjihb
18 Aug 21
Current report (foreign)
12:20pm
6-K
EX-99.4
0tj3w uv007
18 Aug 21
Current report (foreign)
12:20pm
20-F/A
7lzgvw a9taxhwo10
31 Mar 21
Annual report (foreign) (amended)
12:00am
6-K
EX-99.4
9hkfcm 92
3 Feb 21
RepliCel and MainPointe Pharmaceuticals Sign Strategic Investment and Collaboration Agreement
12:03pm
6-K
EX-99.1
q6piine
6 Nov 18
RepliCel Life Sciences Appoints Head of Clinical and Regulatory Affairs
11:03am
20-F/A
9uy4e9 grq5zmo7o9pw1
12 Jan 18
Annual report (foreign) (amended)
12:00am